Reporting to the Sr. Accounting Manager, the Sr. Accountant will be an important contributor to the Company’s accounting and financial-reporting function, with significant responsibility for the monthly, quarterly, and annual close process. This role will help ensure that the Company’s financial records are accurate, complete, timely, well documented, and maintained in compliance with U.S. GAAP, SEC reporting requirements, and the Company’s SOX-compliant internal-control framework.
The incumbent will bring a strong technical accounting background, including required public accounting experience auditing public companies, as well as experience working within a publicly traded company. Biotechnology, pharmaceutical, life-sciences, or other healthcare-industry experience is highly desired. Experience supporting commercial-stage operations including revenue, inventory, cost of goods sold, and gross-to-net accounting is also highly desired.
Physical Demands:
While performing the duties of this job, the employee is regularly required to walk, stand, and sit. The employee must regularly lift and/or move up to 10 pounds. Specific vision abilities required by this individual include close vision, peripheral vision, and the ability to adjust focus. The employee will view a computer monitor for long periods of time.
Home office working environment.
Periodic travel is required. This will include to SAB locations and potentially other locations based on business needs.
The employer will make reasonable accommodations in compliance with the Americans with Disabilities Act of 1990.
This job description will be reviewed periodically as duties and responsibilities change with business necessity. Primary and additional duties and responsibilities are subject to modification.
SAB BIO is an Equal Opportunity Employer and prohibits discrimination and harassment of any kind. SAB BIO is committed to the principle of equal employment opportunity for all employees and does not discriminate based on race, religion, color, sex, gender identify, sexual orientation, age, non-disqualifying physical or mental disability, national origin, veteran status or any other legally protected status. EOE/AA/Vets

At SAB BIO, our mission is to dramatically redefine what it means to be diagnosed with type 1 diabetes (T1D) by developing a medicine to change the course of disease, not just treat symptoms.
SAB BIO is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The Company was founded in 2014 and traded on Nasdaq (SABS) since 2021.
Using advanced genetic engineering and antibody science, SAB BIO developed a proprietary technology which holds the potential to generate additional novel therapeutic candidates utilizing the human immune response, without the need for human donors or convalescent plasma.
To date, SAB BIO has conducted seven clinical trials that have dosed 700 individuals across multiple therapeutic areas. The safety and immunogenicity database for these trials shows zero patients with serum sickness or neutralizing anti-drug antibodies, which suggests an improved safety profile over other therapies.
SAB BIO’s lead product candidate, SAB-142, targets autoimmune T1D with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients.